Actively Recruiting
Impact of Discontinuing Contact Precautions for Extended-spectrum β-lactamase Enterobacteriaceae in a Geriatric Unit
Led by Centre Hospitalier Régional Metz-Thionville · Updated on 2025-04-27
954
Participants Needed
1
Research Sites
341 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This is an interventional multicenter prospective noninferiority non-randomized double-blind controlled before and after study. The aim of this study is to demonstrate that standard precautions alone are not inferior to contact precautions by comparing the incidence density of extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae acquired in geriatric units before and after discontinuing contact precautions.
CONDITIONS
Official Title
Impact of Discontinuing Contact Precautions for Extended-spectrum β-lactamase Enterobacteriaceae in a Geriatric Unit
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adult patient (> 65 years old)
- Patient hospitalized in geriatrics during the study period
- Free and informed consent obtained from the patient (or his trusted person or legal representative) within 48 hours of admission at the geriatric unit
- Patient affiliated to a social security scheme
You will not qualify if you...
- Patient requiring contact precaution for an indication other than ESBL during the stay (COVID-19, classical PCC excluding ESBL, Clostridium difficile PCC, scabies PCC, BHRe PCC)
- Patient's stay period less than 4 days
- Patient under legal protection
- Person deprived of liberty
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
CHR Metz-Thionville/Hôpital Bel Air
Metz, France, 57085
Actively Recruiting
Research Team
L
Laurie RENAUDIN, MD
CONTACT
M
Mathieu LLORENS, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
CROSSOVER
Primary Purpose
PREVENTION
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here